Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Journal of Acquired Immune Deficiency Syndromes (1999)|July 11, 2008
Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and ZimbabweSylvia K Muyingo, A Sarah Walker, Andy Reid, et al.
Vaccine|January 8, 2011
Therapeutic immunization in HIV infected Ugandans receiving stable antiretroviral treatment: a Phase I safety studyCissy Kityo, Stephanie Bousheri, Juliette Akao, et al.
Vaccine|July 22, 2008
Induction of opsonophagocytic killing activity with pneumococcal conjugate vaccine in human immunodeficiency virus-infected Ugandan adultsMeng Chen, Francis Ssali, Maureen Mulungi, et al.
Tropical Medicine & International Health : TM & IH|November 25, 2010
Distribution of HLA-B alleles in a Ugandan HIV-infected adult population: NORA pharmacogenetic substudy of DARTPaula Munderi, Wendy B Snowden, Ann Sarah Walker, et al.
Antiviral Therapy|October 26, 2011
Glomerular dysfunction and associated risk factors over 4-5 years following antiretroviral therapy initiation in AfricaWolfgang Stöhr, Andrew Reid, A Sarah Walker, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 25, 2021
Brief Report: No Differences Between Lopinavir/Ritonavir and Nonnucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy on Clearance of Plasmodium falciparum Subclinical Parasitemia in Adults Living With HIV Starting Treatment (A5297)Douglas Shaffer, Johnstone Kumwenda, Huichao Chen, et al.
The Pediatric Infectious Disease Journal|April 18, 2025
Pharmacokinetics, Safety and Antiviral Activity of Rilpivirine in Antiretroviral-naïve Children With HIV ≥6 to <12 Years Old: Week 48 and Final Analysis of Cohort 2 From the Open-label, Phase 2 PAINT StudyJohan Lombaard, Visal Moolasart, Joseph Lutaakome, et al.
Antiviral Therapy|February 22, 2007
Prevalence, incidence and predictors of severe anaemia with zidovudine-containing regimens in African adults with HIV infection within the DART trialFrancis Ssali, Wolfgang Stöhr, Paula Munderi, et al.
Plos One|May 6, 2010
A randomized, controlled, trial of short cycle intermittent compared to continuous antiretroviral therapy for the treatment of HIV infection in UgandaSteven J Reynolds, Cissy Kityo, Claire W Hallahan, et al.
Antiviral Therapy|July 21, 2012
Lopinavir/ritonavir monotherapy after 24 weeks of second-line antiretroviral therapy in Africa: a randomized controlled trial (SARA)Charles F Gilks, A Sarah Walker, David T Dunn, et al.
Pageof 5